These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29252023)

  • 41. Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia.
    Małecki R; Klimas K; Kujawa A
    J Diabetes Res; 2021; 2021():9947233. PubMed ID: 34007849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
    Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.
    Joseph WS; Quast T; Cogo A; Crompton MG; Yoon MJ; Lamp KC; Culshaw D; Chaves RL
    J Am Podiatr Med Assoc; 2014 Mar; 104(2):159-68. PubMed ID: 24725036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms.
    Kandemir O; Akbay E; Sahin E; Milcan A; Gen R
    J Infect; 2007 May; 54(5):439-45. PubMed ID: 17018235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Most Prevalent Organism in Diabetic Foot Ulcers and Its Drug Sensitivity and Resistance to Different Standard Antibiotics.
    Nageen A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):293-6. PubMed ID: 27097700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers.
    Demetriou M; Papanas N; Panopoulou M; Papatheodorou K; Bounovas A; Maltezos E
    Int J Low Extrem Wounds; 2013 Jun; 12(2):87-93. PubMed ID: 23667099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pseudomonas aeruginosa Infection after Pancreatoduodenectomy: Risk Factors and Clinic Impacts.
    Zhang JF; Zhu HY; Sun YW; Liu W; Huo YM; Liu DJ; Li J; Hua R
    Surg Infect (Larchmt); 2015 Dec; 16(6):769-74. PubMed ID: 26237502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term antibiotic treatment in geriatric diabetic foot infection.
    Weiss A; Karpf A; Luger E; Schmilowitz H; Dekel S; Shapira I
    J Med; 1998; 29(5-6):365-73. PubMed ID: 10503171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers.
    Dumantepe M; Fazliogullari O; Seren M; Uyar I; Basar F
    Growth Factors; 2015 Apr; 33(2):128-32. PubMed ID: 25856197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of microbiological spectrum and risk factors of cellulitis in hospitalized patients.
    Serdar ZA; Akçay SŞ; Inan A; Dağlı O
    Cutan Ocul Toxicol; 2011 Sep; 30(3):221-4. PubMed ID: 21345156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from diabetic foot ulcer patients.
    Zubair M; Malik A; Ahmad J
    Diabetes Metab Syndr; 2011; 5(2):90-2. PubMed ID: 22813410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can we predict vascular status and culture result based through wound status in diabetic foot infection?
    Shin JY; Roh SG; Chang SC; Lee NH
    Medicine (Baltimore); 2019 Mar; 98(12):e14892. PubMed ID: 30896636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective, multi-center study: factors related to the management of diabetic foot infections.
    Ertugrul BM; Oncul O; Tulek N; Willke A; Sacar S; Tunccan OG; Yilmaz E; Kaya O; Ozturk B; Turhan O; Yapar N; Ture M; Akin F
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2345-52. PubMed ID: 22354524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Microbiological profile and antibiotic susceptibility patterns of organisms isolated from diabetic foot ulcers in a Portuguese hospital].
    Cabete J; Martins de Carvalho F; Moniz L; Pinto M; Neves J; Pereira Alves C
    Rev Port Cir Cardiotorac Vasc; 2011; 18(1):53-60. PubMed ID: 22611538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infections with Pseudomonas aeruginosa in Charcot arthropathy of the foot.
    Illgner U; Uekoetter A; Runge S; Wetz HH
    Foot Ankle Int; 2013 Feb; 34(2):234-7. PubMed ID: 23413063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study).
    Commons RJ; Robinson CH; Gawler D; Davis JS; Price RN
    Diabetes Res Clin Pract; 2015 Nov; 110(2):147-57. PubMed ID: 26453263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?
    Zenelaj B; Bouvet C; Lipsky BA; Uçkay I
    Int J Low Extrem Wounds; 2014 Dec; 13(4):263-72. PubMed ID: 25288579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.